References
American Diabetes Association. (2013). Standards of medical care in diabetes—2013. Diabetes Care, 36(Suppl. 1), S11-S66. doi:10.2337/dc13-S011
Anagnostopoulos, A., & Giralt, S. (2002). Critical review on non-myeloablative stem cell transplantation (NST). Critical Reviews in Oncology/Hematology, 44, 175-190.
Antin, J. H. (2002). Clinical practice. Long-term care after hematopoietic-cell transplantation in adults. New England Journal of Medicine, 347, 36-42.
Appelbaum, F. R., Forman, S. J., Negrin, R. S., & Blume, K. G. (Eds.). (2009). Thomas' hematopoietic cell transplantation: Stem cell transplantation (4th ed.). Chichester, UK: Wiley-Blackwell.
Barton-Burke, M., Dwinell, D. M., Kafkas, L., Lavalley, C., Sands, H., Proctor, C., & Johnson, E. (2008). Graft-versus-host disease: A complex long-term side effect of hematopoietic stem cell transplant. Oncology (Williston Park), 22(11, Suppl. Nurse Ed), 31-45.
Butler, S. O., Btaiche, I. F., & Alaniz, C. (2005). Relationship between hyperglycemia and infection in critically ill patients. Pharmacotherapy, 25, 963-976.
Cutler, C., & Antin, J. H. (2005). An overview of hematopoietic stem cell transplantation. Clinics in Chest Medicine, 26, 517-527.
Dean, R. M., & Bishop, M. R. (2003). Graft-versus-host disease: Emerging concepts in prevention and therapy. Current Hematology Reports, 2, 287-294.
Derr, R. L., Hsiao, V. C., & Saudek, C. D. (2008). Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation. Diabetes Care, 31, 1972-1977.
Donihi, A. C., Raval, D., Saul, M., Korytkowski, M. T., & DeVita, M. A. (2006). Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocrine Practice, 12, 358-362.
Egi, M., Bellomo, R., Stachowski, E., French, C. J., & Hart, G. (2006). Variability of blood glucose concentration and short-term mortality in critically ill patients. Anesthesiology, 105, 244-252.
Fernandez-Miranda, C., Guijarro, C., de la Calle, A., Loinaz, C., Gonzalez-Pinto, I., Gomez-Izquierdo, T., … del Palacio, A. (1998). Lipid abnormalities in stable liver transplant recipients—Effects of cyclosporin, tacrolimus, and steroids. Transplant International, 11, 137-142.
Fuji, S., Kim, S. W., Mori, S., Fukuda, T., Kamiya, S., Yamasaki, S., … Takaue, Y. (2007). Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation. Transplantation, 84, 814-820.
Fuji, S., Kim, S. W., Mori, S., Kamiya, S., Yoshimura, K., Yokoyama, H., … Fukuda, T. (2009). Intensive glucose control after allogeneic hematopoietic stem cell transplantation: A retrospective matched-cohort study. Bone Marrow Transplant, 44, 105-111.
Garg, R., Bhutani, H., Alyea, E., & Pendergrass, M. (2007). Hyperglycemia and length of stay in patients hospitalized for bone marrow transplantation. Diabetes Care, 30, 993-994.
Gebremedhin, E., Behrendt, C. E., Nakamura, R., Parker, P., & Salehian, B. (2012). Severe hyperglycemia immediately after allogeneic hematopoietic stem-cell transplantation is predictive of acute graft-versus-host disease. Inflammation, 36, 177-185. doi:10.1007/s10753-012-9533-7
Godbout, J. P., & Glaser, R. (2006). Stress-induced immune dysregulation: Implications for wound healing, infectious disease and cancer. Jouranl of Neuroimmune Pharmacology, 1, 421-427.
Goerner, M., Gooley, T., Flowers, M. E., Sullivan, K. M., Kiem, H. P., Sanders, J. E., … Storb, R. (2002). Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biology of Blood and Marrow Transplantation, 8, 47-56.
Griffith, M. L., Jagasia, M., & Jagasia, S. M. (2010). Diabetes mellitus after hematopoietic stem cell transplantation. Endocrine Practice, 16, 699-706.
Griffith, M. L., Jagasia, M. H., Misfeldt, A. A., Chen, H., Engelhardt, B. G., Kassim, A., … Jagasia, S. M. (2011). Pretransplantation c-peptide level predicts early posttransplantation diabetes mellitus and has an impact on survival after allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation, 17, 86-92.
Hammer, M. J., Casper, C., Gooley, T. A., O'Donnell, P. V., Boeckh, M., & Hirsch, I. B. (2009). The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients. Biology of Blood and Marrow Transplant, 15, 344-351.
Hammer, M. J., & Voss, J. G. (2012). Malglycemia and cancer: Introduction to a conceptual model [Online exclusive]. Oncology Nursing Forum, 39, E275-E287. doi:10.1188/12.ONF.E275-E287
Inzucchi, S. E. (2006). Clinical practice. Management of hyperglycemia in the hospital setting. New England Journal of Medicine, 355, 1903-1911.
Jones, J. A., Qazilbash, M. H., Shih Y. C., Cantor, S. B., Cooksley, C. D., & Elting, L. S. (2008). In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: Clinical and economic outcomes from the Nationwide Inpatient Sample. Cancer, 112, 1096-1105.
Karanes, C., Nelson, G. O., Chitphakdithai, P., Agura, E., Ballen, K. K., Bolan, C. D., … Confer, D. L. (2008). Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biology of Blood and Marrow Transplant, 14(9, Suppl.), 8-15.
Karnchanasorn, R., Malamug, L. R., Jin, R., Karanes, C., & Chiu, K. C. (2012). Association of hyperglycemia with prolonged hospital stay but no effect on engraftment after autologous hematopoietic stem cell transplantation. Endocrine Practice, 18, 508-518.
Klein, C. J., Stanek, G. S., & Wiles, C. E., 3rd. (1998). Overfeeding macronutrients to critically ill adults: Metabolic complications. Journal of the American Dietetic Association, 98, 795-806.
Melnyk, B. M. (2004). Integrating levels of evidence into clinical decision making. Pediatric Nursing, 30, 323-325.
Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., … Umpierrez, G. E. (2009). American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care, 32, 1119-1131.
Ninin, E., Milpied, N., Moreau, P., Andre-Richet, B., Morineau, N., Mahe, B., … Richet, H. (2001). Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clinical Infectious Disease, 33, 41-47.
Pidala, J., Kim, J., Kharfan-Dabaja, M. A., Nishihori, T., Field, T., Perkins, J., … Anasetti, C. (2011). Dysglycemia following glucocorticoid therapy for acute graft-versus-host disease adversely affects transplantation outcomes. Biology of Blood and Marrow Transplantation, 17, 239-248.
Prieto, J. M., Blanch, J., Atala, J., Carreras, E., Rovira, M., Cirera, E., & Gasto, C. (2002). Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. Journal of Clinical Oncology, 20, 1907-1917.
Ramos-Cebrian, M., Torregrosa, J. V., Gutierrez-Dalmau, A., Oppenheimer, F., & Campistol, J. M. (2007). Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation. Transplantation Proceedings, 39, 2251-2253.
Rentschler, L. M. (2010). Association between hyperglycemia and hospital lenght of stay in patietns undergoing hematopoeitic stem cell tranplantation. Endocrinologist, 20, 232-235.
Sheean, P. M., Braunschweig, C., & Rich, E. (2004). The incidence of hyperglycemia in hematopoietic stem cell transplant recipients receiving total parenteral nutrition: A pilot study. Journal of the American Dietetic Association, 104, 1352-1360.
Sheean, P. M., Freels, S. A., Helton, W. S., & Braunschweig, C. A. (2006). Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 12, 656-664.
Turina, M., Christ-Crain, M., & Polk, H. C., Jr. (2006). Diabetes and hyperglycemia: Strict glycemic control. Critical Care Medicine, 34(9, Suppl.), S291-S300.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., … Bouillon, R. (2001). Intensive insulin therapy in critically ill patients. New England Journal of Medicine, 345, 1359-1367.
Vanhorebeek, I., Langouche, L., & Van den Berghe, G. (2007). Tight blood glucose control: What is the evidence? Critical Care Medicine, 35(9, Suppl.), S496-S502.
Whittemore, R., & Knafl, K. (2005). The integrative review: Updated methodology. Journal of Advanced Nursing, 52, 546-553. doi:10.1111/j.1365-2648.2005.03621.x